About this trial
The aim of this study is to develop techniques for non-invasive imaging of biology in participants with benign or malignant renal masses based on the novel scanning MRI techniques, including recently invented Hyperpolarised MRI, deuterium metabolic imaging and sodium MRI. This imaging study will: 1) acquire imaging data from human tissues following the injection of hyperpolarised 13C pyruvate and use 13C-MRI to monitor changes in the ratio of 13C-lactate to 13C-pyruvate; 2) acquire imaging data from human tissues using Sodium MRI or 3) acquire imaging data from human tissues following the oral consumable of deuterated glucose. Data acquired during this physiological study will be used to optimise future imaging protocols.In the UK and possibly in other countries, there are some patients with renal masses that are over treated or undergo unnecessary procedures such as surgery or biopsies, as they are thought to have a malignant tumour or a more aggressive tumour but after the procedure it is found that the mass was benign. The aim of this study is to determine whether one or all of these imaging techniques can differentiate between benign and malignant renal masses with the view to developing the techniques further and hopefully reducing the need for over treatment or unnecessary procedures in patients with benign masses.
Eligibility criteria
Qualifiers
Over 18 years old
Able to and provide written informed consent to participate
If female, postmenopausal or if women of child bearing potential (WOCBP) using a suitable contraception
If male, using a suitable contraceptive method for the duration of the study
Disqualifiers
Contraindication or inability to tolerate MRI
Pregnant or actively breast-feeding woman
If using an intrauterine contraceptive device (IUCD) as a method of contraception the device should be MRI safe at 3 T (researcher to confirm)
Clinically significant cardiac, pulmonary or neurological diseases as determined by the investigators
Trial design
Treatments tested in this trial
- Hyperpolarised MRI
- Sodium MRI
- Deuterium metabolic imaging (DMI) MRI